Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ziopharm oncology revenue
Ziopharm oncology's revenue is $6.4 million.
What is Ziopharm oncology's revenue?
- Ziopharm oncology has 48 employees, and the revenue per employee ratio is $133,125.
- Ziopharm oncology peak revenue was $6.4M in 2024.
On this page
Zippi applies for you, and finds you a job.
Ziopharm oncology financing
Ziopharm oncology received early financing of $18.1M on 2005-06-06.
| Series | Round size | Date |
|---|---|---|
| Series A | $18.1M | 06/2005 |
| Post Ipo Equity | $37M | 05/2006 |
| Post Ipo Equity | $30.9M | 02/2007 |
| Post Ipo Equity | $5M | 09/2009 |
| Grant | $733K | 11/2010 |
| Post Ipo Equity | $57.5M | 01/2015 |
| Post Ipo Equity | $120M | 07/2016 |
| Post Ipo Equity | $8.4M | 09/2019 |
Ziopharm oncology investors
| Investors | Security type |
|---|---|
| Emerging Technology Partners | Post Ipo Equity |
| LBI Group | Post Ipo Equity |
| Cycad Group | Post Ipo Equity |
| ProQuest Investments | Post Ipo Equity |
| Henderson Global Investors | Post Ipo Equity |
| Pangaea Asset Management LLC | Post Ipo Equity |
| Paramount BioCapital Asset Management | Post Ipo Equity |
| LBI Group | Post Ipo Equity |
| ProQuest Investments | Post Ipo Equity |
| Pinto Technology Ventures | Post Ipo Equity |
| Henderson Global Investors | Post Ipo Equity |
| Essex Woodlands Health Ventures | Post Ipo Equity |
Ziopharm oncology competitors
Ziopharm oncology's top competitor, American Air Liquide Holdings, earned an annual revenue of $5.3B.
Ziopharm oncology's smallest competitor is Opexa Therapeutics with revenue of $2.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Opexa Therapeutics | $58,501 | $2.9M | 23 | - |
| American Air Liquide Holdings | $83,932 | $5.3B | 8,197 | - |
| Peregrine Pharmaceuticals | $61,658 | $57.6M | 321 | - |
| Pharmacyclics | $97,383 | $235.0M | 607 | - |
| Amicus Therapeutics | $88,124 | $528.3M | 508 | - |
| Genentech | $97,473 | $166.9M | 13,638 | 469 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Ziopharm oncology highest paying jobs
Zippia gives an in-depth look into the details of Ziopharm oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ziopharm oncology. The employee data is based on information from people who have self-reported their past or current employments at Ziopharm oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ziopharm oncology. The data presented on this page does not represent the view of Ziopharm oncology and its employees or that of Zippia.
Ziopharm oncology may also be known as or be related to ZIOPHARM ONCOLOGY INC, ZIOPHARM Oncology, ZIOPHARM Oncology Inc, ZIOPHARM Oncology, Inc., Ziopharm Oncology, Ziopharm Oncology, Inc. and Ziopharm oncology.